Calmare Therapeutics (CTTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2014 | 03-2014 | 12-2013 | 09-2013 | 06-2013 | |
| Sales | 332 | 228 | 233 | 327 | 150 |
| Cost of Goods | 522 | 465 | -752 | 339 | 325 |
| Gross Profit | -190 | -238 | 984 | -12 | -175 |
| Operating Expenses | 906 | 731 | 872 | 812 | 774 |
| Operating Income | -574 | -504 | -640 | -485 | -624 |
| Interest Expense | 148 | 105 | 66 | 67 | 44 |
| Other Income | -69 | -118 | 95 | -50 | -9 |
| Pre-tax Income | -791 | -726 | -611 | -602 | -677 |
| Net Income Continuous | -791 | -726 | -611 | -602 | -677 |
| Net Income | $-791 | $-726 | $-611 | $-602 | $-677 |
| EPS Basic Total Ops | -0.03 | -0.04 | -0.03 | -0.04 | -0.04 |
| EPS Basic Continuous Ops | -0.03 | -0.04 | -0.03 | -0.04 | -0.04 |
| EPS Diluted Total Ops | -0.03 | -0.04 | -0.03 | -0.04 | -0.04 |
| EPS Diluted Continuous Ops | -0.03 | -0.04 | -0.03 | -0.04 | -0.04 |
| EBITDA(a) | $-461 | $-440 | $-740 | $-379 | $-621 |